Cancer Research and Treatment

Immunohistochemical Characterization of a Large Cohort of Triple Negative Breast Cancer

Rachel Han, Sharon Nofech-Mozes, Dina Boles, Hannah Wu, Nikolina Curcin, Elzbieta Slodkowska

International Journal of Surgical Pathology.2024; 32(2): 239. CrossRef

Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

Laura Lopez-Gonzalez, Alicia Sanchez Cendra, Cristina Sanchez Cendra, Eduardo David Roberts Cervantes, Javier Cassinello Espinosa, Tatiana Pekarek, Oscar Fraile-Martinez, Cielo García-Montero, Ana María Rodriguez-Slocker, Laura Jiménez-Álvarez, Luis G. Gu

TP53R175H mutation promotes breast cancer cell proliferation through CORO1A–P38 MAPK pathway regulation

Yali Su, Jiaxuan Zhao, Haoran Fu, Zeliang Liu, Panyan Du, Jianxia Zheng, Jinghua Wu, Jinghua Zhang

Biochemical Pharmacology.2024; 221: 116047. CrossRef

TP53 and/or BRCA1 Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer

Akiko Arimura, Kazuko Sakai, Kazuhisa Kaneshiro, Takafumi Morisaki, Saori Hayashi, Kimihisa Mizoguchi, Mai Yamada, Masaya Kai, Mayumi Ono, Kazuto Nishio, Masafumi Nakamura, Makoto Kubo

Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy

Journal of Personalized Medicine.2023; 13(2): 190. CrossRef

The role of p53 and ki67 in predicting clinical outcome in breast cancer patients

BhanuPrakash Lalkota, BJ Srinivasa, ManiV Swamy, Diganta Hazarika, BM Jeet, K Jyothi, Mithua Ghosh, SuhailM Sayeed, Mohammad Nasiruddin, Radheshyam Naik

Journal of Cancer Research and Therapeutics.2023; 19(2): 208. CrossRef

Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis

Xing Chang, Zi Liu, Simeng Cao, Jiang Bian, Dayong Zheng, Nuo Wang, Qi Guan, Yingliang Wu, Weige Zhang, Zengqiang Li, Daiying Zuo

Toxicology and Applied Pharmacology.2022; 436: 115883. CrossRef

Targeted gene next‐generation sequencing reveals genomic profile in a cohort of 46 Chinese patients with breast cancer

The Journal of Gene Medicine.2022;[Epub] CrossRef

Effect of the elastin-derived peptides (VGVAPG and VVGPGA) on breast (MCF-7) and lung (A549) cancer cell lines in vitro

Konrad A. Szychowski, Bartosz Skóra, Tadeusz Pomianek

Biomedicine & Pharmacotherapy.2022; 151: 113149. CrossRef

p53 Missense Mutation is Associated with Immune Cell PD-L1 Expression in Triple-Negative Breast Cancer

Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer

Hyo-Jin Kim, Bo-Gyeong Seo, Eun-Chan Seo, Kwang-Min Lee, Cheol Hwangbo

Current Issues in Molecular Biology.2022; 44(12): 5848. CrossRef

An integrative pan-cancer analysis of COPB1 based on data mining

Heyan Chen, Kunlong Li, Yijun Li, Peilin Xie, Jianjun He, Huimin Zhang

Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma

Lauren J. Mills, Logan G. Spector, David A. Largaespada, Lindsay A. Williams

GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature

Patrizia Querzoli, Massimo Pedriali, Rosa Rinaldi, Paola Secchiero, Paolo Giorgi Rossi, Elisabetta Kuhn

Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis

Dharambir Kashyap, Vivek Kumar Garg, Elise N. Sandberg, Neelam Goel, Anupam Bishayee

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer

Weikai Xiao, Guochun Zhang, Bo Chen, Xiaoqing Chen, Lingzhu Wen, Jianguo Lai, Xuerui Li, Min Li, Hao Liu, Jing Liu, Han Han-Zhang, Analyn Lizaso, Ning Liao

Syndrome de Peutz–Jeghers et surveillance mammaire : les nouvelles recommandations à propos d’une observation

Gynécologie Obstétrique Fertilité & Sénologie .2021; 49(10): 795. CrossRef

Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer

Effect of Dickkopf-1 (Dkk-1) and SP600125, a JNK Inhibitor, on Wnt Signaling in Canine Prostate Cancer Growth and Bone Metastases

Wachiraphan Supsavhad, Bardes B. Hassan, Jessica K. Simmons, Wessel P. Dirksen, Said M. Elshafae, Nicole A. Kohart, Aylin A. Demirer, Thomas J. Rosol

TP53 Mutations and Outcomes in Breast Cancer: Reading beyond the Headlines

Ashkan Shahbandi, Hoang D. Nguyen, James G. Jackson

The novel TP53 3′-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection

Feng Zeng, Jianfu Heng, Xinwu Guo, Yue Wang, Wenhan Wu, Lili Tang, Min Chen, Shouman Wang, Hongyu Deng, Jun Wang

Breast Cancer Research and Treatment.2020; 180(1): 237. CrossRef

Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China

Zongbi Yi, Fei Ma, Guohua Rong, Yanfang Guan, Chunxiao Li, Binghe Xu

Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer

Gu Xiao, Devon Lundine, George K. Annor, Jorge Canar, Viola Ellison, Alla Polotskaia, Patrick L. Donabedian, Thomas Reiner, Galina F. Khramtsova, Olufunmilayo I. Olopade, Alexander Mazo, Jill Bargonetti

Genomic analysis of racial differences in triple negative breast cancer

Chang-Sheng Chang, Eiko Kitamura, Joan Johnson, Roni Bollag, Lesleyann Hawthorn

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy

Hyeon Jeong Oh, Jeong Mo Bae, Xianyu Wen, Seorin Jung, Younghoon Kim, Kyung Ju Kim, Nam-Yun Cho, Jung Ho Kim, Sae-Won Han, Tae-You Kim, Gyeong Hoon Kang

British Journal of Cancer.2019; 120(8): 797. CrossRef

Immunostaining for p53 and p16CDKN2A Protein Is Not Predictive of Prognosis for Dogs with Malignant Mammary Gland Neoplasms

John Munday, Harsha Ariyarathna, Danielle Aberdein, Neroli Thomson

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

Paul B. Mullan, Victoria Bingham, Paula Haddock, Gareth W. Irwin, Elaine Kay, Stephen McQuaid, Niamh E. Buckley

Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma

Jing-ping Li, Xiang-mei Zhang, Zhenzhen Zhang, Li-hua Zheng, Sonali Jindal, Yun-jiang Liu

Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis

Fabiola Giudici, Elisabetta Petracci, Oriana Nanni, Cristina Bottin, Maurizio Pinamonti, Fabrizio Zanconati, Bruna Scaggiante, Aamir Ahmad

Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00

Elisabetta Munzone, Kathryn P. Gray, Caterina Fumagalli, Elena Guerini-Rocco, István Láng, Thomas Ruhstaller, Lorenzo Gianni, Roswitha Kammler, Giuseppe Viale, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Meredith M. Regan, Aron Goldhirsch, Massimo B

Breast Cancer Research and Treatment.2018; 170(2): 351. CrossRef

Cold atmospheric plasma conveys selectivity on triple negative breast cancer cells both in vitro and in vivo

Liangjian Xiang, Xiaoyu Xu, Shuo Zhang, Dongyan Cai, Xiaofeng Dai

Free Radical Biology and Medicine.2018; 124: 205. CrossRef

Genetic Markers in Triple-Negative Breast Cancer

Zuzana Sporikova, Vladimira Koudelakova, Radek Trojanec, Marian Hajduch

Clinical Breast Cancer.2018; 18(5): e841. CrossRef

Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy‐treated triple negative breast cancer

Soo Youn Bae, Seung Pil Jung, Se Kyung Lee, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam

The Kaohsiung Journal of Medical Sciences.2018; 34(12): 663. CrossRef

Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients

Yunbao Pan, Yufen Yuan, Guoshi Liu, Yongchang Wei, William B. Coleman

Alcohol promotes migration and invasion of triple‐negative breast cancer cells through activation of p38 MAPK and JNK

Ming Zhao, Erin W. Howard, Amanda B. Parris, Zhiying Guo, Qingxia Zhao, Xiaohe Yang

Molecular Carcinogenesis.2017; 56(3): 849. CrossRef

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis

Zongbi Yi, Fei Ma, Chunxiao Li, Rongrong Chen, Lifang Yuan, Xiaoying Sun, Xiuwen Guan, Lixi Li, Binliang Liu, Yanfang Guan, Haili Qian, Binghe Xu

TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas

Táya F. Oliveira, Tábata Maués, Mariana S. Ramundo, Agnes Marie S. Figueiredo, Marcela F. V. de Mello, Kênia B. El-Jaick, Maria de Lourdes G. Ferreira, Ana Maria R. Ferreira

Journal of Veterinary Diagnostic Investigation.2017; 29(6): 865. CrossRef

Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer

Jisela Dimas-González, Vilma Maldonado-Lagunas, José Díaz-Chávez, María Eugenia López-Arellano, José Muñoz-Camacho, Marco Antonio Terán-Porcayo, Alfredo Lagunas-Martínez

Genomic comparison of esophageal squamous cell carcinoma and its precursor lesions by multi-region whole-exome sequencing

Xi-Xi Chen, Qian Zhong, Yang Liu, Shu-Mei Yan, Zhang-Hua Chen, Shan-Zhao Jin, Tian-Liang Xia, Ruo-Yan Li, Ai-Jun Zhou, Zhe Su, Yu-Hua Huang, Qi-Tao Huang, Li-Yun Huang, Xing Zhang, Yan-Na Zhao, Jin-Ping Yun, Qiu-Liang Wu, Dong-Xin Lin, Fan Bai, Mu-Sheng Z

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes

Ji-Yeon Kim, Eunjin Lee, Kyunghee Park, Woong-Yang Park, Hae Hyun Jung, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park

miR-34a expression in human breast cancer is associated with drug resistance

Zhi-Hua Li, Xueling Weng, Qiu-Yun Xiong, Jian-Hong Tu, An Xiao, Wei Qiu, Yu Gong, Er-Wei Hu, Songyin Huang, Ya-Li Cao

Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer

Min Chong Kim, Jung Eun Choi, Soo Jung Lee, Young Kyung Bae

Annals of Surgical Oncology.2016; 23(11): 3524. CrossRef

2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway

Jingwen Xu, Mengting Han, Jiwei Shen, Qi Guan, Zhaoshi Bai, Binyue Lang, Huijuan Zhang, Zengqiang Li, Daiying Zuo, Weige Zhang, Yingliang Wu